Colgate-Palmolive is due for a turnaround, one analyst says. Here’s what can drive it.
Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone. However, the company’s revenue guidance came in below Wall Street’s expectations.
Why Did Stifel Give Colgate-Palmolive Co (CL) Stock Hold Rating?
Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $89.57 which represents a decrease of $-0.29 or -0.32% from the prior close of $89.86. The stock opened at $90.11 and touched a low of $89.
Is Colgate-Palmolive Company (CL) the Best Diversified Dividend Stock to Buy Now?
We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against the other diversified dividend stocks.
CL Earnings: Surprise Revenue Miss Drops Colgate-Palmolive Stock
Colgate-Palmolive stock was down on Friday after the company missed revenue estimates in its Q4 2024 earnings report.
Colgate-Palmolive: Q4 Earnings Snapshot
The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 89 cents per share. The consumer products maker posted revenue of $4.94 billion in the period, which missed Street forecasts.
Colgate-Palmolive EPS Up, Revenue Lags
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
Colgate-Palmolive (NYSE:CL) Misses Q4 Revenue Estimates
Consumer products company Colgate-Palmolive (NYSE:CL) in Q4 CY2024, with sales flat year on year at $4.94 billion. Its non-GAAP profit of $0.91 per share was 2.3% above analysts’ consensus estimates.
Colgate-Palmolive stock analysis: overvalued ahead of earnings
The Colgate-Palmolive stock price remains in a deep correction as investors wait for the fourth-quarter results. CL has plunged by over 17%, bringing its market cap to about $73 billion. So, is Colgate a good stock to buy the dip in?
Colgate-Palmolive's lackluster guidance upstages solid Q4 results
Shares of Colgate-Palmolive ( NYSE: CL) are trading defensively ahead of Friday’s opening bell as mixed fourth quarter ...
Colgate-Palmolive Co. Q4 Profit Increases, Beats Estimates
Colgate-Palmolive Co. (CL) revealed earnings for its fourth quarter that increased from the same period last year and beat the ...
Colgate-Palmolive Q4: EPS Beat, Sales Miss, Cautious FY25 Forecast And More
Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic ...
Colgate-Palmolive Stock: Post-Earnings Drop Isn't A Buy-The-Dip Moment
Buying Colgate-Palmolive Company shares after their 20% drop may not be a good idea for dividend or total return investors.
Colgate-Palmolive Sees FY25 Earnings, Organic Sales Growth - Update
While reporting financial results for the fourth quarter on Friday, Colgate-Palmolive Co. (CL) initiated its earnings, adjusted ...
Colgate-Palmolive 4Q Sales Slip Lower; 2025 Sales Seen Roughly Flat
Colgate-Palmolive forecast 2025 sales to be roughly flat from last year; sales came in at $20.10 billion in 2024. Write to Denny Jacob at [email protected] ...
Colgate-Palmolive sees weaker annual sales growth on demand slowdown
The company's net sales in Latin America, a major revenue contributing region, fell 7.2 per cent and dropped 1 per cent in ...
Colgate Palmolive India's Q3 profit misses estimates on moderating demand
Colgate Palmolive (India) reported a third-quarter profit that came in below market estimates on Tuesday, hurt by dwindling demand from urban consumers and higher expenses.
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Would you like to be notified of the latest news and updates on the stock market?